Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation☆☆

White, 2000, Congenital adrenal hyperplasia due to 21‐hydroxylase deficiency, Endocr Rev, 21, 245 Krone, 2009, Genetics of congenital adrenal hyperplasia, Best Pract Res Clin Endocrinol Metab, 23, 181, 10.1016/j.beem.2008.10.014 Miller, 2011, The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders, Endocr Rev, 32, 81, 10.1210/er.2010-0013 Pang, 1993, Congenital adrenal hyperplasia due to 21‐hydroxilase deficiency: newborn screening and its relationship to the diagnosis and treatment of disorder, Screening, 2, 105, 10.1016/0925-6164(93)90024-D Speiser, 2010, Congenital adrenal hyperplasia due to steroid 21‐hydroxylase deficiency: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, 95, 4133, 10.1210/jc.2009-2631 Bachega, 2004, Estudo multicêntrico de pacientes brasileiros com deficiência da 21‐hidroxilase: correlação do genótipo com o fenótipo, Arq Bras Endocrinol Metab, 48, 697, 10.1590/S0004-27302004000500016 Silveira, 2009, Molecular analysis of CYP21A2 can optimize the follow‐up of positive results in newborn screening for congenital adrenal hyperplasia, Clin Genet, 76, 503, 10.1111/j.1399-0004.2009.01274.x Prader, 1954, Der Genitalbefund beim Pseudohermaphroditismus Femininus des kongenitalen Adrenogenitalen Syndromes, Helv Paediatr Acta, 3, 231 Hayashi, 2011, Weight‐adjusted neonatal 17OH‐progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia, Arq Bras Endocrinol Metab, 55, 632, 10.1590/S0004-27302011000800019 Olgemöller, 2003, Screening for congenital adrenal hyperplasia: adjustment of 17‐hydroxyprogesterone cut‐off values to both age and birth weight markedly improves the predictive value, J Clin Endocrinol Metab, 88, 5790, 10.1210/jc.2002-021732 Araújo, 2015 Gatelais, 2004, Effect of single and multiple courses of prenatal corticosteroids on 17‐hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia, Pediatr Res, 56, 701, 10.1203/01.PDR.0000142733.50918.6E Balsamo, 2010, Impact of molecular genetics on congenital adrenal hyperplasia management, Sex Dev, 4, 233, 10.1159/000315959 de Carvalho, 2016, Molecular CYP21A2 diagnosis in 480 Brazilian 433 patients with congenital adrenal hyperplasia before newborn screening introduction, Eur J Endocrinol, 175, 107, 10.1530/EJE-16-0171 Falhammar, 2015, Biochemical and genetic diagnosis of 21‐hydroxylase deficiency, Endocrine, 50, 306, 10.1007/s12020-015-0731-6 Silveira, 2008, The actual incidence of congenital adrenal hyperplasia in Brazil may not be as high as inferred: an estimate based on a public neonatal screening program in the state of Goiás, J Pediatr Endocrinol Metab, 21, 455, 10.1515/JPEM.2008.21.5.455 Nascimento, 2014, Ten‐year evaluation of a neonatal screening program for congenital adrenal hyperplasia, Arq Bras Endocrinol Metabol, 58, 765, 10.1590/0004-2730000003310 Kopacek, 2017, Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population‐based study with 108,409 infants, BMC Pediatr, 17, 22, 10.1186/s12887-016-0772-x Prado, 2017, Development of CYP21A2 genotyping assay with potential diagnosis of congenital adrenal hyperplasia, Mol Diagn Ther, 21, 663, 10.1007/s40291-017-0296-6 Krone, 2002, Multiplex minisequencing of the 21‐hydroxylase gene as a rapid strategy to confirm 356 congenital adrenal hyperplasia, Clin Chem, 48, 818, 10.1093/clinchem/48.6.818 Soardi, 2008, Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in Brazilian and Scandinavian patients, J Clin Endocrinol Metab, 93, 2416, 10.1210/jc.2007-2594 Nordenstrom, 1999, Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21‐hydroxylase deficiency, J Clin Endocrinol Metab, 84, 1505 Vakili, 2005, Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21‐hydroxylase deficiency in northeastern Iran, Horm Res, 63, 119 New, 2013, Genotypephenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21‐hydroxylase deficiency, Proc Natl Acad Sci U S A, 110, 2611, 10.1073/pnas.1300057110 Díez López, 2010, Síndrome suprarrenogenital congénito virilizante con mutación de novo I172N: estudio de un nuevo caso, An Pediatr (Barc), 72, 72, 10.1016/j.anpedi.2009.08.006 Frish, 2001, Salt wasting in simple virilizing congenital adrenal hyperplasia, J Clin Endocrinol Metab, 14, 1649 Bachega, 1998, Molecular genotyping in Brazilian patients 446 with the classical and nonclassical forms of 21‐hydroxylase deficiency, J Clin Endocrinol Metab, 83, 4416 Marino, 2011, Steroid 21‐hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype‐phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia, Clin Endocrinol (Oxf), 75, 427, 10.1111/j.1365-2265.2011.04123.x Neocleous, 2012, Genetic defects in the CYP21A2 gene in heterozygous girls with premature adrenarche and adolescent females with hyperandrogenemia, Georgian Med News, 40